# Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"

> **NCT00729937** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 2265 (actual)

## Conditions studied

- Staphylococcal Infection

## Interventions

- **DRUG:** Cephalexin
- **DRUG:** Clindamycin
- **OTHER:** Placebo
- **DRUG:** Trimethoprim-sulfamethoxazole

## Key facts

- **NCT ID:** NCT00729937
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 2265 (ACTUAL)
- **Last updated:** 2015-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00729937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00729937, "Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00729937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*